Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center · New York, New York
Answer a few short questions to share with the research team.